Status:

COMPLETED

Antagonistic Interaction CB1-paracetamol

Lead Sponsor:

University Hospital, Clermont-Ferrand

Conditions:

Pain

Eligibility:

All Genders

18-40 years

Phase:

PHASE1

Brief Summary

Evaluation of an possible inhibiting effect of Rimonabant on the analgesic effect of Paracetamol in healthy volunteers

Detailed Description

Double Blind, cross-over, randomized and controlled versus placebo, study in healthy volunteers.

Eligibility Criteria

Inclusion

  • Healthy volunteers
  • between 18 and 40 years old
  • written consent given

Exclusion

  • Rimonabant or paracetamol hypersensibility
  • Excessive consumption of alcohol, tobacco, coffee, tea or toxicomania
  • Concomitant medication
  • Chronical diseases

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2008

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT00750347

Start Date

September 1 2008

End Date

October 1 2008

Last Update

January 19 2011

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

CIC-CPC

Clermont-Ferrand, France, 63000

2

CHU Clermont-Ferrand

Clermont-Ferrand, France, 63003